Lansforsakringar Fondforvaltning AB publ Has $28.91 Million Stake in Synopsys, Inc. $SNPS

Lansforsakringar Fondforvaltning AB publ lifted its position in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 24.3% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 58,588 shares of the semiconductor company’s stock after purchasing an additional 11,454 shares during the quarter. Lansforsakringar Fondforvaltning AB publ’s holdings in Synopsys were worth $28,907,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. Stanley Laman Group Ltd. lifted its holdings in Synopsys by 542.9% during the 3rd quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock worth $6,353,000 after buying an additional 10,874 shares in the last quarter. Symphony Financial Ltd. Co. boosted its holdings in Synopsys by 4,780.9% in the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock valued at $20,638,000 after acquiring an additional 39,395 shares during the last quarter. Bank of New York Mellon Corp grew its position in shares of Synopsys by 0.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock worth $691,035,000 after buying an additional 4,815 shares during the period. Waverton Investment Management Ltd grew its holdings in Synopsys by 15.0% during the 2nd quarter. Waverton Investment Management Ltd now owns 578,299 shares of the semiconductor company’s stock worth $296,630,000 after acquiring an additional 75,374 shares during the period. Finally, Motley Fool Asset Management LLC increased its holdings in Synopsys by 13.4% in the second quarter. Motley Fool Asset Management LLC now owns 9,757 shares of the semiconductor company’s stock valued at $5,002,000 after purchasing an additional 1,156 shares during the last quarter. 85.47% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on SNPS. Morgan Stanley lifted their price target on shares of Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. KeyCorp raised their price objective on Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research note on Thursday, December 11th. Needham & Company LLC boosted their target price on Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. JPMorgan Chase & Co. increased their price target on Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. Finally, Citigroup assumed coverage on Synopsys in a report on Monday, November 24th. They set a “buy” rating and a $580.00 price objective on the stock. Nine equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $547.00.

Get Our Latest Stock Analysis on Synopsys

More Synopsys News

Here are the key news stories impacting Synopsys this week:

Insider Activity at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Janet Lee sold 250 shares of the business’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider directly owned 11,959 shares in the company, valued at $6,338,270. This trade represents a 2.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 4,157 shares of company stock valued at $1,945,036 over the last three months. Insiders own 0.62% of the company’s stock.

Synopsys Stock Down 0.6%

Synopsys stock opened at $439.94 on Monday. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73. The company has a fifty day simple moving average of $474.06 and a 200 day simple moving average of $481.90. The company has a market cap of $84.27 billion, a P/E ratio of 55.06, a price-to-earnings-growth ratio of 3.66 and a beta of 1.12.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company’s quarterly revenue was up 37.8% on a year-over-year basis. During the same period in the prior year, the business posted $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Research analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Further Reading

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.